Published in J Infect Dis on March 01, 1985
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J Virol (1999) 1.32
Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med (1997) 1.23
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine. Antimicrob Agents Chemother (1992) 1.07
Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance. J Virol (2002) 1.06
Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol (1998) 1.03
Modification of acute murine cytomegalovirus adrenal gland infection by adoptive spleen cell transfer. J Virol (1987) 1.02
Animal cytomegaloviruses. Microbiol Rev (1990) 1.02
Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother (1985) 0.97
Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus. Virol J (2006) 0.94
T-lymphocyte effects on murine cytomegalovirus pulmonary infection. Am J Pathol (1990) 0.83
Pneumonitis in bone marrow transplant recipients results from a local immune response. Clin Exp Immunol (1990) 0.82
Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis. Viral Immunol (2015) 0.75
Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis (1978) 2.07
Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet (1987) 1.89
Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol (1977) 1.79
Infective endocarditis with negative blood cultures. An analysis of 52 cases. Am J Med (1979) 1.73
Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages. Infect Immun (1979) 1.48
Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis (1981) 1.43
Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage. J Exp Med (1975) 1.43
Metabolic and synthetic activities of Pneumocystis carinii in vitro. Infect Immun (1981) 1.38
The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis (1982) 1.32
Pathogenesis of reactivated latent murine cytomegalovirus infection. Am J Pathol (1979) 1.28
Clinical aspects of CNS cysticercosis. Arch Intern Med (1980) 1.27
Murine cytomegalovirus adrenalitis in athymic nude mice. Arch Virol (1986) 1.26
Nonphagocytic clearance of Staphylococcus aureus from murine lungs. Infect Immun (1982) 1.23
Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA (1992) 1.23
Phagolysosome formation in normal and colchicine-treated macrophages. J Exp Med (1975) 1.19
Suramin effects on macrophage phagolysosome formation and antimicrobial activity. Infect Immun (1978) 1.17
In vitro effects of antiprotozoan drugs and immune serum on Pneumocystis carinii. J Infect Dis (1980) 1.12
Intracellular localization of the herpes simplex virus type-1 origin binding protein, UL9. Virology (1996) 1.11
Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells. Infect Immun (1987) 1.11
Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med (1983) 1.11
Effects of bacterial pneumonitis on development of pneumocystosis in rats. Am Rev Respir Dis (1982) 1.07
Pneumocystis carinii: oxygen uptake, antioxidant enzymes, and susceptibility to oxygen-mediated damage. Infect Immun (1984) 1.06
Replication of murine cytomegalovirus in lung macrophages: effect of phagocytosis of bacteria. Infect Immun (1980) 1.06
Modification of acute murine cytomegalovirus adrenal gland infection by adoptive spleen cell transfer. J Virol (1987) 1.02
Review of 59 patients hospitalized with animal bites. Pediatr Infect Dis J (1987) 1.01
Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis (1983) 1.00
Phagocytosis of hematopoietic cells by blast cells in blast crisis of chronic myelocytic leukemia. West J Med (1977) 0.98
Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J Gen Virol (1998) 0.98
Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother (1985) 0.97
Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation (1985) 0.96
Chronic glucocorticosteroid therapy impairs staphylococcal clearance from murine lungs. Infect Immun (1982) 0.96
Murine peritoneal macrophages support murine cytomegalovirus replication. Infect Immun (1983) 0.95
Quantitative RT-PCR using a PCR-generated competitive internal standard. Biotechniques (1997) 0.95
Host genetic factors influence murine cytomegalovirus lung infection and interstitial pneumonitis. J Gen Virol (1984) 0.95
Protection of staphylococci ingested by macrophages from the bactericidal action of rifampin. Antimicrob Agents Chemother (1980) 0.94
Tracheal function during influenza infections. Infect Immun (1983) 0.93
The murine cytomegalovirus M25 open reading frame encodes a component of the tegument. Virology (1999) 0.93
Staphylococcal clearance and pulmonary macrophage function during influenza infection. Infect Immun (1982) 0.92
Glycoproteins of Pneumocystis carinii: characterization by electrophoresis and microscopy. J Infect Dis (1988) 0.92
Sequence requirements for the nuclear localization of the murine cytomegalovirus M44 gene product pp50. Virology (1999) 0.92
Lack of detectable activity of ornithine decarboxylase in Pneumocystis carinii. J Infect Dis (1988) 0.91
Effects of antiviral agents on murine cytomegalovirus-induced macrophage dysfunction. Infect Immun (1982) 0.91
Chronic pericarditis due to a streptomyces species. Am J Clin Pathol (1979) 0.90
Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays. J Clin Microbiol (1987) 0.89
Effects of L3T4+ lymphocyte depletion on acute murine cytomegalovirus infection. J Gen Virol (1989) 0.86
Kinetics of phagocytosis of Staphylococcus aureus by alveolar and peritoneal macrophages. Infect Immun (1979) 0.85
Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer (1978) 0.85
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms. JAMA (1977) 0.84
Inhibition of macrophage phagocytosis after contact with ingestible particles. J Reticuloendothel Soc (1981) 0.84
Replication of murine cytomegalovirus in murine Y-1 cells. J Med Virol (1979) 0.83
Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function. J Immunol (1990) 0.82
Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells. Exp Hematol (1997) 0.81
Encephalomyocarditis virus can bind to and transfect non-permissive cells. Arch Virol (1986) 0.81
Evaluation of PCR and nested PCR for laboratory diagnosis of hepatitis C virus infection. Mol Cell Probes (1996) 0.80
Ultraviolet irradiation of murine cytomegalovirus. J Gen Virol (1982) 0.80
Adaptations of phagocytosis and pinocytosis in mouse lung macrophages after sustained in vitro hypoxia. Am Rev Respir Dis (1981) 0.80
Pseudomonas aeruginosa clearance in mice: comparison of tissue, strain, and corticosteroid effects. Infect Immun (1984) 0.80
Transfer of murine cytomegalovirus infection by heart transplantation. Transplantation (1983) 0.79
Enzyme-linked immunosorbent assay for immunoglobulin G antibody to encephalomyocarditis virus. J Clin Microbiol (1980) 0.79
Characterization of a 52K protein of murine cytomegalovirus and its immunological cross-reactivity with the DNA-binding protein ICP36 of human cytomegalovirus. J Gen Virol (1991) 0.78
A purified procoagulant enzyme from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus): in vivo and in vitro studies. J Lab Clin Med (1972) 0.78
Verapamil inhibits influenza A virus replication. Arch Virol (1984) 0.78
Murine cytomegalovirus-induced macrophage dysfunction. J Leukoc Biol (1984) 0.78
Modulation of pulmonary clearance of bacteria by antioxidants. Infect Immun (1985) 0.77
Human cytomegalovirus replicates in gamma-irradiated fibroblasts. J Med Virol (1986) 0.77
Alteration of bronchoalveolar cells during murine cytomegalovirus interstitial pneumonitis. Am Rev Respir Dis (1985) 0.77
Infection with the human immunodeficiency virus (HIV) as a risk factor for bacteremic illness due to Streptococcus pneumoniae. Conn Med (1988) 0.77
Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor. J Virol (1990) 0.76
Altered threshold for the induction of graft-versus-host immunodeficiency following murine cytomegalovirus infection. Host and donor contributions. Transplantation (1988) 0.76
Replication of human cytomegalovirus in cells deficient in beta 2-microglobulin gene expression. J Gen Virol (1994) 0.76
Role of surface wettability in phagocytosis of Neurospora crassa spores. J Reticuloendothel Soc (1979) 0.75
Intrapulmonary growth of Staphylococcus aureus in rats during induced atelectasis. Infect Immun (1987) 0.75
Coronary ostial embolus and mitral vegetation simulating a left atrial myxoma: a case of probable cryptococcal valvulitis. Clin Cardiol (1979) 0.75
Murine cytomegalovirus and Pneumocystis carinii. J Infect Dis (1984) 0.75
Immunosuppression reactivates and disseminates latent murine cytomegalovirus. IARC Sci Publ (1978) 0.75
Replication of encephalomyocarditis virus in various mammalian cell types. J Med Virol (1983) 0.75
Haemophilus aphrophilus. Arch Neurol (1979) 0.75
Pretreatment antibody titers in repeated rabies prophylaxis. JAMA (1980) 0.75
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus. J Infect Dis (1988) 0.75
Thrombic enzyme from Crotalus adamanteus. Lancet (1970) 0.75
Spinal cord compression due to anaerobic vertebral osteomyelitis in a patient with metastatic prostate cancer. Clin Infect Dis (1995) 0.75
When phagocytic dysfunction increases susceptibility to infectious diseases. Geriatrics (1977) 0.75
The effect of short-chain fatty acids on the susceptibility of human umbilical vein endothelial cells to human cytomegalovirus infection. J Virol Methods (1994) 0.75
Mantle-cell lymphoma in a patient with human immunodeficiency viral infection. Acta Haematol (1995) 0.75
Adrenal gland lesions with murine cytomegalovirus. Ann Intern Med (1984) 0.75
Chlamydia and CMV in pneumonitis. N Engl J Med (1977) 0.75
Periodic sharp complexes in herpes simplex virus encephalitis: survival in an elderly man. Clin Electroencephalogr (1987) 0.75
Noninvasive detection of fungal endocarditis. Chest (1979) 0.75